Aptamer-Functionalized AuNR Nanoplatform for Active Targeted Chemo-Photothermal Therapy of Tumor
Bioconjugate Chemistry · 2026
DOI: 10.1021/acs.bioconjchem.5c00607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Hui Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Shanxi Provincial Key Laboratory of Chemical Biosensing, Shanxi Datong University, Datong 037009, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Doxorubicin, Gold, Photothermal Therapy. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Shanxi Normal University, Shanxi Datong University, Program for the Scientific Activities of Selected Returned Overseas Professionals in Shaanxi Province.
Abstract (Originalsprache)
Chemo-photothermal therapy has emerged as a promising approach for clinical tumor treatment, effectively circumventing drug resistance and minimizing the side effects associated with chemotherapy (CHT) drugs. However, this therapeutic strategy is significantly limited by the poor accumulation capacity of the nanomaterials. In pursuit of innovative nanomaterials for precise diagnosis and effective treatment, an active targeted nanoplatform AuNR/Apt-M@DOX was constructed. This nanoplatform was fabricated by integrating gold nanorods (AuNR) with a polymorphic epithelial mucin (MUC1) aptamer (Apt-M). Concurrently, doxorubicin (DOX) was intercalated into the DNA double helix formed by Apt-M, enabling targeted drug delivery. Facilitated by Apt-M-mediated recognition and endocytosis, the nanoplatform was selectively delivered into the tumor site. Subsequently, the excellent photothermal properties of AuNR under NIR irradiation enabled effective photothermal therapy (PTT). Meanwhile, a weak acidic environment and NIR laser simultaneously triggered the release of DOX, achieving chemotherapy (CHT). Under NIR laser irradiation, the nanoplatform exhibited excellent performance in chemo-photothermal therapy and successfully inhibited tumor growth. This work presents a novel concept of a nanoplatform for enhanced tumor ablation, dual stimuli-responsive drug release, and the combination of CHT and PTT in a drug-loaded nanoplatform.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Shanxi Provincial Key Laboratory of Chemical Biosensing, Shanxi Datong University, Datong 037009, China.
- School of Chemistry and Material Science, Shanxi Normal University, Taiyuan 030002, China.
- School of Medical, Shanxi Datong University, Datong 037009, China.
- School of Agriculture and Life Science, Shanxi Datong University, Datong 037009, China.
ORCID-Profile: Yunfeng Bai, Feng Feng
Förderung
- Shanxi Normal University
- Shanxi Datong University
- Program for the Scientific Activities of Selected Returned Overseas Professionals in Shaanxi Province
- National Natural Science Foundation of China
- Key Scientific and Technological Projects of Datong City
- Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi
- Fundamental Research Program of Datong City
- Fundamental Research Program of Shanxi Province
Zitieren
APA
Xu, H., Zhao, L., Chen, X., Wang, A., Li, J., Bai, Y., & Feng, F. (2026). Aptamer-Functionalized AuNR Nanoplatform for Active Targeted Chemo-Photothermal Therapy of Tumor. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.5c00607
Vancouver
Xu H, Zhao L, Chen X, Wang A, Li J, Bai Y, et al. Aptamer-Functionalized AuNR Nanoplatform for Active Targeted Chemo-Photothermal Therapy of Tumor. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.5c00607
BibTeX
@article{Xu2026,
author = {Xu, Hui and Zhao, Lu and Chen, Xiaoliang and Wang, Aiai and Li, Jianfeng and Bai, Yunfeng and Feng, Feng},
title = {Aptamer-Functionalized AuNR Nanoplatform for Active Targeted Chemo-Photothermal Therapy of Tumor},
journal = {Bioconjugate Chemistry},
year = {2026},
doi = {10.1021/acs.bioconjchem.5c00607}
}
EUVIMED